BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22711575)

  • 1. Radiation treatment generates therapy-resistant cancer stem cells from less aggressive breast cancer cells.
    Printz C
    Cancer; 2012 Jul; 118(13):3225. PubMed ID: 22711575
    [No Abstract]   [Full Text] [Related]  

  • 2. GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line.
    Li B; Cheng XL; Yang YP; Li ZQ
    Oncol Rep; 2013 Nov; 30(5):2119-26. PubMed ID: 24002052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiation-induced G2 phase arrest may contribute to the radioresistance of breast cancer stem cells].
    Tian YH; Xie GZ; Ren C; Sun QQ; Sun AM; Liu Y; Yuan YW
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):53-6. PubMed ID: 21269956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cells: obstacles to therapy.
    Smalley M; Piggott L; Clarkson R
    Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
    Croker AK; Allan AL
    Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer stem cell].
    Sakashita H; Ieta K; Haraguchi N; Inoue Y; Yoshizawa Y; Mori M
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1721-9. PubMed ID: 18030004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor initiating cancer stem cells from human breast cancer cell lines.
    Han JS; Crowe DL
    Int J Oncol; 2009 May; 34(5):1449-53. PubMed ID: 19360358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of breast cancer stem cells: potential clinical applications.
    Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
    Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD49d+/high subpopulation from isolated human breast sarcoma spheres possesses tumor-initiating ability.
    Lee KM; Han W; Kim JB; Shin I; Ko E; Park IA; Lee DS; Oh K; Noh DY
    Int J Oncol; 2012 Mar; 40(3):665-72. PubMed ID: 22159714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
    Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A
    Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stem cells: treatment resistance and therapeutic opportunities.
    Al-Ejeh F; Smart CE; Morrison BJ; Chenevix-Trench G; López JA; Lakhani SR; Brown MP; Khanna KK
    Carcinogenesis; 2011 May; 32(5):650-8. PubMed ID: 21310941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer stem cells: a new target for lung cancer treatment].
    Rivera S; Rivera C; Loriot Y; Hennequin C; Vozenin MC; Deutsch E
    Cancer Radiother; 2011 Aug; 15(5):355-64. PubMed ID: 21664165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro.
    Hornung R; Walt H; Crompton NE; Keefe KA; Jentsch B; Perewusnyk G; Haller U; Köchli OR
    Photochem Photobiol; 1998 Oct; 68(4):569-74. PubMed ID: 9796440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.
    Chang BD; Broude EV; Dokmanovic M; Zhu H; Ruth A; Xuan Y; Kandel ES; Lausch E; Christov K; Roninson IB
    Cancer Res; 1999 Aug; 59(15):3761-7. PubMed ID: 10446993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytological characteristics of the changes in breast cancer cells under the action of radiotherapy].
    Shul'gina OS
    Lab Delo; 1975; (9):535-8. PubMed ID: 52745
    [No Abstract]   [Full Text] [Related]  

  • 17. Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy.
    Lu D; Chen S; Tan X; Li N; Liu C; Li Z; Liu Z; Stupack DG; Reisfeld RA; Xiang R
    Cancer Res; 2012 Jul; 72(14):3451-6. PubMed ID: 22586064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stem cells and epithelial cancers: the example of breast cancer].
    Charafe-Jauffret E; Ginestier C; Monville F; Wicinski J; Bertucci F; Viens P; Xerri L; Cabaud O; Dontu G; Wicha MS; Birnbaum D
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S30-2. PubMed ID: 18984292
    [No Abstract]   [Full Text] [Related]  

  • 19. [ZNF703: a novel oncogene involved in breast cancer].
    Ginestier C; Sircoulomb F; Charafe-Jauffret E; Chaffanet M; Birnbaum D
    Med Sci (Paris); 2011 Apr; 27(4):357-9. PubMed ID: 21524397
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer stem cells: an approach to identify newer therapeutic targets.
    Srivastava S; Krishna S
    J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.